Not applicableLooking for participantsNCT06225505What this trial is testingEarly Detection of Triple Negative Breast Cancer Relapse (CUPCAKE)Who this might be right forTriple Negative Breast Cancer Institut Curie 450
Early research (Phase 1)Study completedNCT03739931What this trial is testingDose Escalation Study of mRNA-2752 for Intratumoral Injection to Participants in Advanced MalignanciesWho this might be right forDose Escalation: Relapsed/Refractory Solid Tumor Malignancies or LymphomaDose Expansion: Triple Negative Breast Cancer, HNSCC, Non-Hodgkins, Urothelial Cancer, Immune Checkpoint Refractory Melanoma, and NSCLC Lymphoma ModernaTX, Inc. 134
Testing effectiveness (Phase 2)Looking for participantsNCT07410494What this trial is testingBiomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid TumorsWho this might be right forCancerBreast CancerNon-Small Cell Lung Cancer (NSCLC)+10 more Essen Biotech 85
Early research (Phase 1)Study completedNCT00569283What this trial is testingDonor Natural Killer Cell Infusion in Preventing Relapse or Graft Failure in Patients Who Have Undergone Donor Bone Marrow TransplantWho this might be right forCancer Asan Medical Center 18
Large-scale testing (Phase 3)Active Not RecruitingNCT06764186What this trial is testingA Phase IIIB Study to Evaluate the Use of Capivasertib in Combination With Fulvestrant in Patients With Advanced Breast Cancer Who Have Relapsed/Progressed on ET and CDK4/6 Inhibitor Reflecting Real World Clinical Practice in SpainWho this might be right forLocally Advanced or Metastatic Breast Cancer AstraZeneca 101
Testing effectiveness (Phase 2)WithdrawnNCT02850419What this trial is testingHeat-Activated Target Therapy of Local-Regional Relapse in Breast Cancer PatientsWho this might be right forBreast Cancer Imunon
Large-scale testing (Phase 3)Active Not RecruitingNCT04595565What this trial is testingSacituzumab Govitecan in Primary HER2-negative Breast CancerWho this might be right forHER2-negative Breast CancerTriple Negative Breast Cancer GBG Forschungs GmbH 1,332
Large-scale testing (Phase 3)Ended earlyNCT00053911What this trial is testingCombination Chemotherapy Compared With Observation After Surgery in Treating Women With Relapsed Nonmetastatic Breast CancerWho this might be right forBreast Cancer UNICANCER
Early research (Phase 1)UnknownNCT00769613What this trial is testingEmergency Use of Donor Lymphocytes in Treating Patients Who Have Undergone Donor Stem Cell Transplant and Have Cytomegalovirus InfectionsWho this might be right forCancer Milton S. Hershey Medical Center 20
Early research (Phase 1)Ended earlyNCT02890368What this trial is testingTrial of Intratumoral Injections of TTI-621 in Subjects With Relapsed and Refractory Solid Tumors and Mycosis FungoidesWho this might be right forSolid TumorsMycosis FungoidesMelanoma+5 more Pfizer 56
Very early researchUnknownNCT05180851What this trial is testingSafety and Efficacy of Recombinant Oncolytic Adenovirus L-IFN Injection in Relapsed/Refractory Solid Tumors Clinical StudyWho this might be right forHead and Neck CancerMelanomaBreast Cancer+4 more Shanghai Fengxian District Central Hospital 28
Not applicableEnded earlyNCT00949052What this trial is testingGenetic Susceptibility and Risk of Second Cancers in Patients Who Have Undergone Stem Cell Transplant for CancerWho this might be right forCancer Vanderbilt-Ingram Cancer Center 1,000
Early research (Phase 1)Enrolling By InvitationNCT07218003What this trial is testingA Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4Who this might be right forNon Small Cell Lung CancerCervical CancerHead and Neck Squamous Cell Cancer+7 more Rondo Therapeutics 149
Testing effectiveness (Phase 2)Ended earlyNCT00617929What this trial is testingAntithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell TransplantWho this might be right forCancer Masonic Cancer Center, University of Minnesota 12
Testing effectiveness (Phase 2)Ended earlyNCT00462865What this trial is testingTrial of Chemotherapy and Avastin as Treatment for Women With Breast Cancer at High Risk for RelapseWho this might be right forBreast Cancer Brown University 18
Not applicableWithdrawnNCT04985357What this trial is testingDefining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to DrugsWho this might be right forStage III Breast CancerStage IV Breast CancerStage III Lung Cancer+35 more Travera Inc
Early research (Phase 1)Ended earlyNCT05274451What this trial is testingInvestigate LYL797 in Adults With Solid TumorsWho this might be right forTriple Negative Breast CancerTNBC - Triple-Negative Breast CancerNon-small Cell Lung Cancer+20 more Lyell Immunopharma, Inc. 57
Testing effectiveness (Phase 2)Ended earlyNCT00479856What this trial is testingLapatinib In Combination With Chemotherapy In Subjects With Relapsed Breast CancerWho this might be right forRelapsed Breast CancerNeoplasms, Breast GlaxoSmithKline 9
Testing effectiveness (Phase 2)Ended earlyNCT00461344What this trial is testingDocetaxel + Doxorubicin as Neoadjuvant Chemotherapy in Patients With Breast CancerWho this might be right forDuctal Carcinoma Sanofi 20
Early research (Phase 1)Study completedNCT01295632What this trial is testingSafety and Tolerability of Different Dose Combinations of Ridaforolimus With MK-2206 or MK-0752 for Participants With Advanced Cancer (MK-8669-049)Who this might be right forAdvanced Cancer Merck Sharp & Dohme LLC 65